- IN₹174.48bn
- IN₹144.05bn
- IN₹25.20bn
Israeli study shows 4th shot of COVID-19 vaccine not able to block Omicron
Refinitiv Newscasts - Trading at Noon: Wall Street on track for third year of gains
Refinitiv Newscasts - U.S. Day Ahead: Biden urges boosters
Refinitiv Newscasts - Trading at Noon: Producer prices heat up
WHO exec: donated COVID-19 vaccines with short shelf life 'major problem'
Refinitiv Newscasts - Asia Insight: SE Asia stocks rally turns choppy as hot U.S. inflation looms
Refinitiv Newscasts - UK Day Ahead: Tui to report widening loss
Refinitiv Newscasts - UK Day Ahead: Euro zone & UK services data to show vulnerability amid rising prices, Omicron
Egypt authorizes Pfizer's COVID-19 vaccine for 12 to 15 year-olds
India's Pfizer Ltd jumps as parent company says antiviral pill cuts risk of severe COVID-19 by 89%
Refinitiv Newscasts - U.S. Morning Call: Jobs, Dollar, Uber, Peloton, Pfizer, Merck
Refinitiv Newscasts - Trading at Noon: Federal Reserve to detail end to QE
Brief: India's Pfizer Says Sept-Quarter Net Profit Rose
Sinovac's COVID shot highly effective against serious illness- Malaysia study
Refinitiv Newscasts - Asia Insight: India plan for tighter e-commerce rules faces internal government dissent
Booster jabs are easy money for Pfizer and Moderna
Brief: India's Pfizer Ltd June-Qtr Net Profit Rises
Indonesia approves Pfizer COVID-19 vaccine for emergency use
Brief: India's Pfizer Ltd Reports March-Quarter Net Profit Of 1.01 Billion Rupees